Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04579692 · ClinicalTrials.gov registry record · NA

MR Guided Focused Ultrasound (FUS) for the Treatment of Trigeminal Neuralgia

A NA study of Trigeminal Neuralgia, sponsored by University of Maryland, Baltimore.

Active
Registry status
NA
Development phase
10
Enrollment target
1
Study location

NCT04579692 is a NA study of Trigeminal Neuralgia that is active but no longer recruiting, run by University of Maryland, Baltimore. The registered enrollment target is 10 participants, below the 5,769-participant average among 9 other Trigeminal Neuralgia trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04579692, a NA study of Trigeminal Neuralgia, is active but no longer recruiting, sponsored by University of Maryland, Baltimore.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
10 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to assess the safety and effectiveness of MRI-guided focused ultrasound (MRgFUS) for treating Trigeminal Neuralgia. Trigeminal Neuralgia (pain) is a type of pain involving the face that can be disabling to those it affects.

Conditions Studied

Interventions

  • DEVICE ExAblate Transcranial treatment

Study Locations (1)

Maryland

  • University of Maryland Medical Center - Baltimore

Trial Details

FieldValue
Enrollment Target 10 participants
Start Date 2021-08-16
Est. Completion 2026-05-28
Phase NA

Sponsor

University of Maryland, Baltimore

560 total trials

What the Registry Record Tells You About NCT04579692

The ClinicalTrials.gov registry entry for NCT04579692 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 10 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 5,769-participant average among 9 other Trigeminal Neuralgia trials with a reported enrollment target (100% lower). The listed sponsor is University of Maryland, Baltimore, which has 560 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Trigeminal Neuralgia appearing as the primary indexed condition, and to 1 intervention - of which ExAblate Transcranial treatment is the first listed.

NCT04579692 reports 1 study location spanning 1 distinct geographic area - top geographies include Maryland.

Frequently Asked Questions

What is clinical trial NCT04579692 about?

NCT04579692 is a clinical study titled "MR Guided Focused Ultrasound (FUS) for the Treatment of Trigeminal Neuralgia". The purpose of this study is to assess the safety and effectiveness of MRI-guided focused ultrasound (MRgFUS) for treating Trigeminal Neuralgia. Trigeminal Neuralgia (pain) is a type of pain involving the face that can be disabling to those it affects.

What is the current status of trial NCT04579692?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 10 participants. The study started on 2021-08-16. Estimated completion is 2026-05-28.

What conditions does trial NCT04579692 study?

This clinical trial studies the following conditions: Trigeminal Neuralgia.

What interventions are being tested in trial NCT04579692?

The interventions under investigation include: ExAblate Transcranial treatment (DEVICE).

Who is sponsoring clinical trial NCT04579692?

This trial is sponsored by University of Maryland, Baltimore, which has 560 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04579692 being conducted?

This trial has 1 study location across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Trigeminal Neuralgia

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.